AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
暂无分享,去创建一个
I. V. Van Gelder | M. Rienstra | L. Fauchier | G. Parati | K. Vernooy | M. Brignole | L. Calò | L. Mont | F. Quartieri | E. Occhetta | M. Gasparini | C. Allaart | M. Landolina | D. Soranna | V. V. van Dijk | P. Palmisano | F. Pentimalli | G. Mascia | V. V. van Dijk
[1] D. Mark,et al. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure , 2021, Circulation.
[2] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.
[3] M. Brignole,et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS , 2018, European heart journal.
[4] L. Jordaens,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.
[5] L. Fauchier,et al. Mortality After Atrioventricular Nodal Radiofrequency Catheter Ablation With Permanent Ventricular Pacing in Atrial Fibrillation: Outcomes From a Controlled Nonrandomized Study , 2016, Circulation. Arrhythmia and electrophysiology.
[6] B. Olshansky,et al. Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality , 2015, Cardiology research and practice.
[7] Andy Y Lee,et al. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial. , 2015, Heart rhythm.
[8] P. Kirchhof,et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis , 2014, The Lancet.
[9] Mei Xue,et al. Effects of Atrioventricular Nodal Ablation on Permanent Atrial Fibrillation Patients With Cardiac Resynchronization Therapy: A Systematic Review and Meta‐analysis , 2014, Clinical cardiology.
[10] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[11] G. Boriani,et al. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). , 2013, JACC. Heart failure.
[12] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[13] M. Ezekowitz,et al. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. , 2013, American heart journal.
[14] Tommy Andersson,et al. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study , 2013, European heart journal.
[15] J. Healey,et al. Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation: Results From the Resynchronization for Ambulatory Heart Failure Trial (RAFT) , 2012, Circulation. Heart failure.
[16] 임재영,et al. BMI(Body Mass Index)가 소득에 미치는 영향 , 2012 .
[17] M. Brignole,et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. , 2011, European heart journal.
[18] Otto Kamp,et al. Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.
[19] P. Tchou,et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.
[20] W. Shen,et al. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials. , 2007, Heart rhythm.
[21] L. Saul. Cardiac Resynchronization Therapy , 2007, Critical care nursing quarterly.
[22] Jeroen J. Bax,et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. , 2006, Journal of the American College of Cardiology.
[23] F. Prinzen,et al. Ventricular remodeling during long-term right ventricular pacing following His bundle ablation. , 2006, The American journal of cardiology.
[24] E. Daoud,et al. Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) , 2005, Journal of cardiovascular electrophysiology.
[25] W. Maisel,et al. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.
[26] B. Gersh,et al. Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation , 2001 .
[27] G. Kay,et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.
[28] F. Morady,et al. Effect of an irregular ventricular rhythm on cardiac output. , 1996, The American journal of cardiology.
[29] W. H. Herbert. Cardiac output and the varying R-R interval of atrial fibrillation. , 1973, Journal of electrocardiology.
[30] ReviewTM. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes , 2022 .